Abstract 917: AZD2014, a dual mTORC1 and mTORC2 inhibitor is differentiated from allosteric inhibitors of mTORC1 in ER+ breast cancerSylvie M. Guichard, Martin Pass, Zoë Howard et al.|Cancer Research|2012Cited by 17
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s DiseaseLongbin Liu, Ignacio Muñoz-Sanjuán, Andrew J. Stott et al.|Journal of Medicinal Chemistry|2023Cited by 7